Israel on Thursday said it will send a high level research delegation to India to conduct a series of "final stages of testing" as part of a joint effort to develop rapid testing kits for COVID-19 to detect the presence of the virus in the body within 30 seconds, in what could be a respite from the global pandemic and open opportunities for both the countries to market the solution together.

Merging Israel's technological expertise with India's mass production capabilities, experts from the two countries have joined hands to develop the rapid testing kits for COVID-19, officials said.

A high ranking team from the Directorate of Defence Research and Development (DDR&amp;D), in the Israel Ministry of Defense, which has been working with India's DRDO to develop rapid testing for COVID-19 in under 30 seconds, is to leave from Tel Aviv to New Delhi on a special flight in a few days, Israel's Ministry of Defence said in a statement.

Israel's Ministry of Foreign Affairs (MFA) and Ministry of Health are also involved in this unprecedented cooperation between the two countries which aims at "merging Israeli technology with Indian development and production capabilities to allow a swift resumption of normal life alongside the virus".

The DDR&amp;D team will conduct a series of "final stages of testing" to determine the effectiveness of number of rapid diagnostic solutions with their Indian counterparts.

Since the start of the pandemic, the DDR&amp;D has tested dozens of diagnostic technologies. Some of them have matured and passed initial trials in Israel, however in order to complete testing and prove their effectiveness, these must be tested on a wide range of patients, IMoD said.

The four tech systems that will be tested are - voice test, breathalyzer test based on terra-hertz waves, isothermal test, and polyamino acids test.

"What they all have in common is the ability to detect the presence of the virus in the body quickly- usually within minutes. Developing diagnostic capabilities is a goal for the State of Israel and of many additional countries around the world. It is the most effective way to cut off 'chains of infection', prevent prolonged quarantine and enable the reopening of the global economy", the statement said.

"We hope that the research and development led by the DDR&amp;D together with our excellent industries and academic institutions, will lead to a breakthrough that will change the way we diagnose and fight the virus, while giving the boost necessary to 'restart' our economy," Defense Minister Benny Gantz said.

Foreign Minister Gabi Ashkenazi noted that this cooperation provides a unique opportunity for scientific and technological cooperation that can assist Israel, India and the world in coping both with the pandemic and with the economic crisis that came with it.

The cooperation between Israel and India will enable the delegation and its Indian counterparts, to collect tens of thousands of samples in just ten days, and analyze them using computer systems based on artificial intelligence. This massive sampling will shorten processes and advance the approval of effective technology. All tests will be validated using PCR tests.

"The cooperation between India and Israel on COVID-19 is a good example of harnessing the scientific and technological strengths that the two countries have for larger, common good. It will also further deepen our strategic ties," India's Ambassador Sanjeev Singla said.

The flight will be carrying some breakthrough emerging Israeli technologies for combatting COVID-19, which have been donated by the Israeli foreign ministry and the private sector, in order to bolster India's response to the virus outbreak.

The plane will also deliver mechanical ventilators which were given special permission by Israel for export to India.

Prime Minister Narendra Modi and his Israeli counterpart Benjamin Netanyahu have held three telephonic conversations since the outbreak of the pandemic and promised mutual assistance in dealing with the virus, committing to joint technological and scientific research between the countries.

The Israeli media widely reported that Modi lifted a ban on the export of Hydroxychloroquine at Netanyahu's request.

"The past few years have cemented the strategic relations between India and Israel and have included two historical visits of the Prime Ministers in Israel and in India," a press statement from the ministry of defence said.

"India seeks to integrate advanced technologies in its hospitals as they prepare to treat massive waves of COVID-19 patients on an Indian scale. The Israeli companies chosen by the MFA, MOD and Israel Defence Forces to be sent to India are potentially given unique access to one of the largest economies in the world to provide monitoring and treatment technologies while significantly reducing contact between the patients and the medical staff," it said.

"By opening the door to India's market with its development and production capabilities, these Israeli technologies can be mass produced at a lower cost and could in future be jointly exported to third countries," it said.

"India and Israel's military R&amp;D cooperation is well known for its success. I have no doubt the same will be seen in the private sector joined by brilliant scientific minds from both countries to introduce a breakthrough in swift and simple testing procedures," said Prof. Nati Keller, an infectious diseases specialist from Sheba Medical Center, who is leading the medical side of the team.

Israel on Thursday said it will send a high level research delegation to India to conduct a series of "final stages of testing" as part of a joint effort to develop rapid testing kits for COVID-19 to detect the presence of the virus in the body within 30 seconds, in what could be a respite from the global pandemic and open opportunities for both the countries to market the solution together.

Israel on Thursday said it will send a high level research delegation to India to conduct a series of "final stages of testing" as part of a joint effort to develop rapid testing kits for COVID-19 to detect the presence of the virus in the body within 30 seconds, in what could be a respite from the global pandemic and open opportunities for both the countries to market the solution together. Merging Israel's technological expertise with India's mass production capabilities, experts from the two countries have joined hands to develop the rapid testing kits for COVID-19, officials said. A high ranking team from the Directorate of Defence Research and Development (DDR&D), in the Israel Ministry of Defense, which has been working with India's DRDO to develop rapid testing for COVID-19 in under 30 seconds, is to leave from Tel Aviv to New Delhi on a special flight in a few days, Israel's Ministry of Defence said in a statement. Israel's Ministry of Foreign Affairs (MFA) and Ministry of Health are also involved in this unprecedented cooperation between the two countries which aims at "merging Israeli technology with Indian development and production capabilities to allow a swift resumption of normal life alongside the virus". The DDR&D team will conduct a series of "final stages of testing" to determine the effectiveness of number of rapid diagnostic solutions with their Indian counterparts. Since the start of the pandemic, the DDR&D has tested dozens of diagnostic technologies. Some of them have matured and passed initial trials in Israel, however in order to complete testing and prove their effectiveness, these must be tested on a wide range of patients, IMoD said. The four tech systems that will be tested are - voice test, breathalyzer test based on terra-hertz waves, isothermal test, and polyamino acids test. "What they all have in common is the ability to detect the presence of the virus in the body quickly- usually within minutes. Developing diagnostic capabilities is a goal for the State of Israel and of many additional countries around the world. It is the most effective way to cut off 'chains of infection', prevent prolonged quarantine and enable the reopening of the global economy", the statement said. "We hope that the research and development led by the DDR&D together with our excellent industries and academic institutions, will lead to a breakthrough that will change the way we diagnose and fight the virus, while giving the boost necessary to 'restart' our economy," Defense Minister Benny Gantz said. Foreign Minister Gabi Ashkenazi noted that this cooperation provides a unique opportunity for scientific and technological cooperation that can assist Israel, India and the world in coping both with the pandemic and with the economic crisis that came with it. The cooperation between Israel and India will enable the delegation and its Indian counterparts, to collect tens of thousands of samples in just ten days, and analyze them using computer systems based on artificial intelligence. This massive sampling will shorten processes and advance the approval of effective technology. All tests will be validated using PCR tests. "The cooperation between India and Israel on COVID-19 is a good example of harnessing the scientific and technological strengths that the two countries have for larger, common good. It will also further deepen our strategic ties," India's Ambassador Sanjeev Singla said. The flight will be carrying some breakthrough emerging Israeli technologies for combatting COVID-19, which have been donated by the Israeli foreign ministry and the private sector, in order to bolster India's response to the virus outbreak. The plane will also deliver mechanical ventilators which were given special permission by Israel for export to India. Prime Minister Narendra Modi and his Israeli counterpart Benjamin Netanyahu have held three telephonic conversations since the outbreak of the pandemic and promised mutual assistance in dealing with the virus, committing to joint technological and scientific research between the countries. The Israeli media widely reported that Modi lifted a ban on the export of Hydroxychloroquine at Netanyahu's request. "The past few years have cemented the strategic relations between India and Israel and have included two historical visits of the Prime Ministers in Israel and in India," a press statement from the ministry of defence said. "India seeks to integrate advanced technologies in its hospitals as they prepare to treat massive waves of COVID-19 patients on an Indian scale. The Israeli companies chosen by the MFA, MOD and Israel Defence Forces to be sent to India are potentially given unique access to one of the largest economies in the world to provide monitoring and treatment technologies while significantly reducing contact between the patients and the medical staff," it said. "By opening the door to India's market with its development and production capabilities, these Israeli technologies can be mass produced at a lower cost and could in future be jointly exported to third countries," it said. "India and Israel's military R&D cooperation is well known for its success. I have no doubt the same will be seen in the private sector joined by brilliant scientific minds from both countries to introduce a breakthrough in swift and simple testing procedures," said Prof. Nati Keller, an infectious diseases specialist from Sheba Medical Center, who is leading the medical side of the team.

India, Israel to jointly develop rapid COVID-19 testing kits

Trader He Ximing in the Chinese city of Wuhan says he has no idea how or where he caught the coronavirus or why repeated nucleic acid tests showed he didn't have it.

He was not a coronavirus patient, doctors told him, even though he had been having difficulty breathing with what he described as smothering chest congestion from early February.

Also read:&nbsp;<a href="https://www.wionews.com/india-news/covid-19-rapid-testing-paused-due-to-issues-with-chinese-kits-293997" hreflang="en">COVID-19: Rapid testing paused due to issues with Chinese kits</a>

But his condition worried the authorities enough to get him sent to a quarantine centre.

Still, he did not challenge the three negative tests at the time. After all, his wife did not fall sick.

But he could not shake off the nagging suspicion that he had the coronavirus and in late March went to a hospital in Wuhan for more tests, including one for antibodies. This time he tested positive.

Also read:&nbsp;<a href="https://www.wionews.com/world/coronavirus-crisis-is-not-going-away-anytime-soon-who-294110" hreflang="en">Coronavirus crisis is not going away anytime soon: WHO</a>

"I didn't expect it," the 52-year-old vegetable seller said as he showed Reuters a copy of his test results - positive for antibodies showing exposure to the coronavirus.

Finally, at least, he had an explanation for why he felt so terrible. "I felt like I was dying. You can't imagine how it feels."

His case is not unique. Similar instances in China and elsewhere have compounded concern over the accuracy of coronavirus testing, even as authorities push for testing as key to handling the crisis.

Unreliable testing could undermine strategies not just for stopping the virus but for opening up locked-down economies, as pressure grows on governments around the world to ease restrictions.

More than 2.5 million people have been infected with the coronavirus globally and about 177,000 have died, according to a Reuters tally.

Wuhan, where the new coronavirus emerged late last year, has recorded 50,333 cases and 3,869 deaths as of April 21, accounting for the majority of China's cases.

Nucleic acid testing, on samples swabbed from the back of a patient's throat or respiratory tract, for the virus' genome, is the main way cases are detected.

The test is not easy to administer and, experts say, and mistakes do happen, such as if too small a sample is taken or if the swab misses a virus-hit spot.

"The limitations of these tests need to be recognised, and the need to run regular tests if we want assurance that someone is truly negative, and that they remain so over a period of time," said Andrew Preston, a lecturer in microbial pathogenesis at the University of Bath.

There is little consensus on what proportion of nucleic acid tests yield false negatives.

A survey by Chinese doctors in February looking at samples from 213 patients suggested a false-negative rate of about 30 per cent.

Media has also reported cases of people testing negative repeatedly before finally getting a positive result.

In February, the People's Daily newspaper reported on a woman who had fallen ill with pneumonia but tested negative for the coronavirus four times. A fifth test was positive.

Wuhan authorities have started testing residents for antibodies. China is conducting an epidemiological survey in nine regions in an effort to determine the full extent of asymptomatic infections and immunity levels.&nbsp;

He said he first got tested on March 1 when his chest congestion worsened though he had no fever or cough.

X-rays showed his lungs had white blotches, similar to those found in coronavirus patients, but his nucleic acid test was not positive so a hospital declined to admit him.

As a precaution, a committee that manages his housing compound put him in quarantine for 14 days.

Later, two more hospital tests came back negative so he turned to traditional Chinese medicine and other drugs.

Finally, on March 28, he took a fourth nucleic acid test, which was again negative, but he was also tested for antibodies and got confirmation.

"I told my story to a doctor and he said 'you're so lucky you didn't die'," he said in his apartment, where boxes of various medicines were scattered about.

His wife, who he lives alone with, has shown no coronavirus symptoms though she has not been tested.

He said he believed he was immune and not infectious, though he's taking no chances and wears an N95 mask and a face shield when going out.

"If there’s any possibility that I'll infect others, I'll harm them," he said. "That’s why I’m taking these precautions."

Trader He Ximing in the Chinese city of Wuhan says he has no idea how or where he caught the coronavirus or why repeated nucleic acid tests showed he didn't have it.

Trader He Ximing in the Chinese city of Wuhan says he has no idea how or where he caught the coronavirus or why repeated nucleic acid tests showed he didn't have it. He was not a coronavirus patient, doctors told him, even though he had been having difficulty breathing with what he described as smothering chest congestion from early February. Also read: COVID-19: Rapid testing paused due to issues with Chinese kits But his condition worried the authorities enough to get him sent to a quarantine centre. Still, he did not challenge the three negative tests at the time. After all, his wife did not fall sick. But he could not shake off the nagging suspicion that he had the coronavirus and in late March went to a hospital in Wuhan for more tests, including one for antibodies. This time he tested positive. Also read: Coronavirus crisis is not going away anytime soon: WHO "I didn't expect it," the 52-year-old vegetable seller said as he showed Reuters a copy of his test results - positive for antibodies showing exposure to the coronavirus. Finally, at least, he had an explanation for why he felt so terrible. "I felt like I was dying. You can't imagine how it feels." His case is not unique. Similar instances in China and elsewhere have compounded concern over the accuracy of coronavirus testing, even as authorities push for testing as key to handling the crisis. Unreliable testing could undermine strategies not just for stopping the virus but for opening up locked-down economies, as pressure grows on governments around the world to ease restrictions. More than 2.5 million people have been infected with the coronavirus globally and about 177,000 have died, according to a Reuters tally. Wuhan, where the new coronavirus emerged late last year, has recorded 50,333 cases and 3,869 deaths as of April 21, accounting for the majority of China's cases. Nucleic acid testing, on samples swabbed from the back of a patient's throat or respiratory tract, for the virus' genome, is the main way cases are detected. The test is not easy to administer and, experts say, and mistakes do happen, such as if too small a sample is taken or if the swab misses a virus-hit spot. "The limitations of these tests need to be recognised, and the need to run regular tests if we want assurance that someone is truly negative, and that they remain so over a period of time," said Andrew Preston, a lecturer in microbial pathogenesis at the University of Bath. There is little consensus on what proportion of nucleic acid tests yield false negatives. A survey by Chinese doctors in February looking at samples from 213 patients suggested a false-negative rate of about 30 per cent. Media has also reported cases of people testing negative repeatedly before finally getting a positive result. In February, the People's Daily newspaper reported on a woman who had fallen ill with pneumonia but tested negative for the coronavirus four times. A fifth test was positive. Wuhan authorities have started testing residents for antibodies. China is conducting an epidemiological survey in nine regions in an effort to determine the full extent of asymptomatic infections and immunity levels. He said he first got tested on March 1 when his chest congestion worsened though he had no fever or cough. X-rays showed his lungs had white blotches, similar to those found in coronavirus patients, but his nucleic acid test was not positive so a hospital declined to admit him. As a precaution, a committee that manages his housing compound put him in quarantine for 14 days. Later, two more hospital tests came back negative so he turned to traditional Chinese medicine and other drugs. Finally, on March 28, he took a fourth nucleic acid test, which was again negative, but he was also tested for antibodies and got confirmation. "I told my story to a doctor and he said 'you're so lucky you didn't die'," he said in his apartment, where boxes of various medicines were scattered about. His wife, who he lives alone with, has shown no coronavirus symptoms though she has not been tested. He said he believed he was immune and not infectious, though he's taking no chances and wears an N95 mask and a face shield when going out. "If there’s any possibility that I'll infect others, I'll harm them," he said. "That’s why I’m taking these precautions."

Three negatives and a positive: Problems with coronavirus tests in China

The Indian Council of Medical Research has said that the rapid testing kits distributed to different states in India by the center will have to be validated before they could be put to use. Watch report.

ICMR: COVID-19 rapid testing kits needs validation first